House Bill 4640
116th Congress(2019-2020)
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019
Introduced
Introduced in House on Oct 11, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4640
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Peter DeFazio
grade
Oregon
Arizona
California
Connecticut
Illinois
Illinois
Maine
Ohio
Tennessee
Texas
Vermont
Wisconsin
No House votes have been held for this bill.
Summary
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019
This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.
October 11, 2019
10/14/2019
Referred to the Subcommittee on Health.
10/11/2019
Referred to the House Committee on Energy and Commerce.
10/11/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:42 PM